Idiopathic intracranial hypertension and obesity

Hormone Research in Paediatrics

Volumn 81, Issue 4, 2014, Pages 217-225

  Andrews, Laura E ^c   Liu, Grant T ^d   Ko, Melissa W ^a,b,c  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b Department of Ophthalmology ^*  (Canada)

^c SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Idiopathic intracranial hypertension, pediatric; Obesity; Pseudotumor cerebri; Recurrence; Weight gain

Indexed keywords

BIOLOGICAL MARKER; MINERALOCORTICOID RECEPTOR; ACETAZOLAMIDE;

ADULT DISEASE; BARIATRIC SURGERY; BRAIN PSEUDOTUMOR; CEREBROSPINAL FLUID; CHILDHOOD DISEASE; HUMAN; IDIOPATHIC INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; NEUROENDOCRINE SYSTEM; NOMENCLATURE; OBESITY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; WEIGHT GAIN; WEIGHT REDUCTION; ADULT; CHILD; COMPLICATION; FEMALE; MALE; PSEUDOTUMOR CEREBRI; BODY MASS; DISEASE SEVERITY; INCIDENCE; OUTCOME ASSESSMENT; SYSTEMATIC REVIEW; VISUAL IMPAIRMENT; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; CHILD; FEMALE; HUMANS; MALE; OBESITY; PSEUDOTUMOR CEREBRI;

EID: 84901640464     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000357730     Document Type: Review

References (68)

1. Friedman DI, Liu GT, Digre KB: Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013; 81: 1-7.
2. Degnan AJ, Levy LM: Pseudotumor cerebri: brief review of clinical syndrome and imaging findings. AJNR Am J Neuroradiol 2011; 32: 1986-1993.
3. Giuseffi V, Wall M, Siegel PZ, Rojas PB: Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology 1991; 41: 239-244.
4. Soler D, Cox T, Bullock P, Calver DM, Robinson RO: Diagnosis and management of benign intracranial hypertension. Arch Dis Child 1998; 78: 89-94.
5. Babikian P, Corbett J, Bell W: Idiopathic intracranial hypertension in children: the Iowa experience. J Child Neurol 1994; 9: 144-149.
6. Lim M, Kurian M, Penn A, Calver D, Lin JP: Visual failure without headache in idiopathic intracranial hypertension. Arch Dis Child 2005; 90: 206-210.
7. Phillips PH, Repka MX, Lambert SR: Pseudotumor cerebri in children. J AAPOS 1998; 2: 33-38.
8. Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O'Fallon WM: Idiopathic intracranial hypertension (pseudotumor cerebri): descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol 1993; 50: 78-80.
9. Lessell S: Pediatric pseudotumor cerebri (idiopathic intracranial hypertension). Surv Ophthalmol 1992; 37: 155-166.
10. Kesler A, Fattal-Valevski A: Idiopathic intracranial hypertension in the pediatric population. J Child Neurol 2002; 17: 745-748.
11. Salman MS, Kirkham FJ, MacGregor DL: Idiopathic 'benign' intracranial hypertension: case series and review. J Child Neurol 2001; 16: 465-470.
12. Salpietro V, Mankad K, Kinali M, et al: Pediatric idiopathic intracranial hypertension and the underlying endocrine-metabolic dysfunction: a pilot study. J Pediatr Endocrinol Metab 2014; 27: 107-115.
13. Ko MW, Liu GT: Pediatric idiopathic intracranial hypertension (pseudotumor cerebri). Horm Res Paediatr 2010; 74: 381-389.
14. Biousse V, Bruce BB, Newman NJ: Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 2012; 83: 488-494.
15. Ooi LY, Walker BR, Bodkin PA, Whittle IR: Idiopathic intracranial hypertension: can studies of obesity provide the key to understanding pathogenesis? Br J Neurosurg 2008; 22: 187-194.
16. Dandy WE: Intracranial pressure without brain tumor: diagnosis and treatment. Ann Surg 1937; 106: 492-513.
17. Smith JL: Whence pseudotumor cerebri? J Clin Neuroophthalmol 1985; 5: 55-56.
18. Friedman DI, Jacobson DM: Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002; 59: 1492-1495.
19. Walker RW: Idiopathic intracranial hypertension: any light on the mechanism of the raised pressure? J Neurol Neurosurg Psychiatry 2001; 71: 1-5.
20. Zada G, Tirosh A, Kaiser UB, Laws ER, Woodmansee WW: Cushing's disease and idiopathic intracranial hypertension: case report and review of underlying pathophysiological mechanisms. J Clin Endocrinol Metab 2010; 95: 4850-4854.
21. Salpietro V, Polizzi A, Berte LF, et al: Idiopathic intracranial hypertension: a unifying neuroendocrine hypothesis through the adrenal-brain axis. Neuro Endocrinol Lett 2012; 33: 569-573.
22. Khan MU, Khalid H, Salpietro V, Weber KT: Idiopathic intracranial hypertension associated with either primary or secondary aldosteronism. Am J Med Sci 2013; 346: 194-198.
23. Salpietro V, Ruggieri M, Sancetta F, et al: New insights on the relationship between pseudotumor cerebri and secondary hyperaldosteronism in children. J Hypertens 2012; 30: 629-630.
24. Malozowski S, Tanner LA, Wysowski D, Fleming GA: Growth hormone, insulin-like growth factor I, and benign intracranial hypertension. N Engl J Med 1993; 329: 665-666.
25. Darendeliler F, Karagiannis G, Wilton P: Headache, idiopathic intracranial hypertension and slipped capital femoral epiphysis during growth hormone treatment: a safety update from the KIGS database. Horm Res 2007; 68(suppl 5):41-47.
26. Besch D, Makowski C, Steinborn MM, Bonfig W, Sadowski B: Visual loss without headache in children with pseudotumor cerebri and growth hormone treatment. Neuropediatrics 2013; 44: 203-207.
27. Durcan FJ, Corbett JJ, Wall M: The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana. Arch Neurol 1988; 45: 875-877.
28. Craig JJ, Mulholland DA, Gibson JM: Idiopathic intracranial hypertension: incidence, presenting features and outcome in Northern Ireland (1991-1995). Ulster Med J 2001; 70: 31-35.
29. Carta A, Bertuzzi F, Cologno D, Giorgi C, Montanari E, Tedesco S: Idiopathic intracranial hypertension (pseudotumor cerebri): descriptive epidemiology, clinical features, and visual outcome in Parma, Italy, 1990 to 1999. Eur J Ophthalmol 2004; 14: 48-54.
30. Kesler A, Gadoth N: Epidemiology of idiopathic intracranial hypertension in Israel. J Neuroophthalmol 2001; 21: 12-14.
31. Yabe I, Moriwaka F, Notoya A, Ohtaki M, Tashiro K: Incidence of idiopathic intracranial hypertension in Hokkaido, the northernmost island of Japan. J Neurol 2000; 247: 474-475.
32. Radhakrishnan K, Thacker AK, Bohlaga NH, Maloo JC, Gerryo SE: Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study. J Neurol Sci 1993; 116: 18-28.
33. Raoof N, Sharrack B, Pepper IM, Hickman SJ: The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. Eur J Neurol 2011; 18: 1266-1268.
34. Kim TW, Choung HK, Khwarg SI, Hwang JM, Yang HJ: Obesity may not be a risk factor for idiopathic intracranial hypertension in Asians. Eur J Neurol 2008; 15: 876-879.
35. Liu IH, Wang AG, Yen MY: Idiopathic intracranial hypertension: clinical features in Chinese patients. Jpn J Ophthalmol 2011; 55: 138-142.
36. Kapoor KG: Regarding 'obesity may not be a risk factor for idiopathic intracranial hypertension in Asians'. Eur J Neurol 2009; 16:e1, author reply e2.
37. Tibussek D, Distelmaier F, von Kries R, Mayatepek E: Pseudotumor cerebri in childhood and adolescence-results of a Germany-wide ESPED-survey. Klin Padiatr 2013; 225: 81-85.
38. Ogden CL, Carroll MD, Kit BK, Flegal KM: Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA 2012; 307: 483-490.
39. Brara SM, Koebnick C, Porter AH, Langer-Gould A: Pediatric idiopathic intracranial hypertension and extreme childhood obesity. J Pediatr 2012; 161: 602-607.
40. Kesler A, Goldhammer Y, Gadoth N: Do men with pseudomotor cerebri share the same characteristics as women? A retrospective review of 141 cases. J Neuroophthalmol 2001; 21: 15-17.
41. Digre KB, Corbett JJ: Pseudotumor cerebri in men. Arch Neurol 1988; 45: 866-872.
42. Bruce BB, Kedar S, Van Stavern GP, et al: Idiopathic intracranial hypertension in men. Neurology 2009; 72: 304-309.
43. Fraser JA, Bruce BB, Rucker J, et al: Risk factors for idiopathic intracranial hypertension in men: a case-control study. J Neurol Sci 2010; 290(1-2):86-89.
44. Daniels AB, Liu GT, Volpe NJ, et al: Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 2007; 143: 635-641.
45. Rowe FJ, Sarkies NJ: The relationship between obesity and idiopathic intracranial hypertension. Int J Obes Relat Metab Disord 1999; 23: 54-59.
46. Ireland B, Corbett JJ, Wallace RB: The search for causes of idiopathic intracranial hypertension: a preliminary case-control study. Arch Neurol 1990; 47: 315-320.
47. Ko MW, Chang SC, Ridha MA, et al: Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study. Neurology 2011; 76: 1564-1567.
48. Johnson LN, Krohel GB, Madsen RW, March GA Jr: The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 1998; 105: 2313-2317.
49. Salpietro V, Chimenz R, Arrigo T, Ruggieri M: Pediatric idiopathic intracranial hypertension and extreme childhood obesity: a role for weight gain. J Pediatr 2013; 162: 1084.
50. Newborg B: Pseudotumor cerebri treated by rice reduction diet. Arch Intern Med 1974; 133: 802-807.
51. Sinclair AJ, Burdon MA, Nightingale PG, et al: Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ 2010; 341:c2701.
52. Kupersmith MJ, Gamell L, Turbin R, Peck V, Spiegel P, Wall M: Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 1998; 50: 1094-1098.
53. Szewka AJ, Bruce BB, Newman NJ, Biousse V: Idiopathic intracranial hypertension: relation between obesity and visual outcomes. J Neuroophthalmol 2013; 33: 4-8.
54. Baldwin MK, Lobb B, Tanne E, Egan R: Weight and visual field deficits in women with idiopathic intracranial hypertension. J Womens Health (Larchmt) 2010; 19: 1893-1898.
55. Sugerman HJ, Felton WL 3rd, Salvant JB Jr, Sismanis A, Kellum JM: Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology 1995; 45: 1655-1659.
56. Sugerman HJ, Felton WL 3rd, Sismanis A, Kellum JM, DeMaria EJ, Sugerman EL: Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg 1999; 229: 634-640, discussion 640-642.
57. Fridley J, Foroozan R, Sherman V, Brandt ML, Yoshor D: Bariatric surgery for the treatment of idiopathic intracranial hypertension. J Neurosurg 2011; 114: 34-39.
58. Chandra V, Dutta S, Albanese CT, Shepard E, Farrales-Nguyen S, Morton J: Clinical resolution of severely symptomatic pseudotumor cerebri after gastric bypass in an adolescent. Surg Obes Relat Dis 2007; 3: 198-200.
59. Kesler A, Kliper E, Shenkerman G, Stern N: Idiopathic intracranial hypertension is associated with lower body adiposity. Ophthalmology 2010; 117: 169-174.
60. Ball AK, Sinclair AJ, Curnow SJ, et al: Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance? Clin Endocrinol (Oxf) 2009; 70: 863-869.
61. Sugerman HJ, DeMaria EJ, Felton WL 3rd, Nakatsuka M, Sismanis A: Increased intraabdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology 1997; 49: 507-511.
62. Sheehan JP: Hormone replacement treatment and benign intracranial hypertension. Br Med J (Clin Res Ed) 1982; 284: 1675-1676.
63. Lampl Y, Eshel Y, Kessler A, et al: Serum leptin level in women with idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 2002; 72: 642-643.
64. Dhungana S, Sharrack B, Woodroofe N: Cytokines and chemokines in idiopathic intracranial hypertension. Headache 2009; 49: 282-285.
65. Subramanian PS, Goldenberg-Cohen N, Shukla S, Cheskin LJ, Miller NR: Plasma ghrelin levels are normal in obese patients with idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 2004; 138: 109-113.
66. Behbehani R, Mabrook A, Abbas JM, Al-Rammah T, Mojiminiyi O, Doi SA: Is cerebrospinal fluid leptin altered in idiopathic intracranial hypertension? Clin Endocrinol (Oxf) 2010; 72: 851-852.
67. Galvin JA, Van Stavern GP: Clinical characterization of idiopathic intracranial hypertension at the Detroit Medical Center. J Neurol Sci 2004; 223: 157-160.
68. Celebisoy N, Secil Y, Akyurekli O: Pseudotumor cerebri: etiological factors, presenting features and prognosis in the western part of Turkey. Acta Neurol Scand 2002; 106: 367-370.